Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06295835 · ClinicalTrials.gov registry record · NA
Method Comparison Study for Measuring Potassium (K) and Ionized Calcium (iCa) in Blood
A NA study of Potassium (K) & Ionized Calcium (iCa) in Capillary Whole Blood, sponsored by Abbott Point of Care.
- Completed
- Registry status
- NA
- Development phase
- 232
- Enrollment target
- 4
- Study locations
NCT06295835 is a NA study of Potassium (K) & Ionized Calcium (iCa) in Capillary Whole Blood that has completed, run by Abbott Point of Care. The registered enrollment target is 232 participants. The trial reports 4 study locations across 4 states.
The verdict
NCT06295835, a NA study of Potassium (K) & Ionized Calcium (iCa) in Capillary Whole Blood, has completed, sponsored by Abbott Point of Care.
- COMPLETED
- Registry status
- NA
- Development phase
- 232 participants
- Enrollment target
- 4
- Study locations
Study Summary
Method comparison study for Potassium (K) and ionized calcium (iCa).
Conditions Studied
Interventions
- DIAGNOSTIC_TEST Fingerstick blood draw
Study Locations (4)
Maryland
- University of Maryland (UMD) - Baltimore
Pennsylvania
- Penn State University Hershey Medical Center (Hershey) - Hershey
Washington
- Eastside Research Associates (ERA) - Redmond
Ontario
- Abbott Point of Care (APOC) - Ottawa
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 232 participants |
| Start Date | 2024-05-31 |
| Est. Completion | 2025-01-29 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06295835
The ClinicalTrials.gov registry entry for NCT06295835 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 232 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Abbott Point of Care, which has 8 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Potassium (K) & Ionized Calcium (iCa) in Capillary Whole Blood appearing as the primary indexed condition, and to 1 intervention - of which Fingerstick blood draw is the first listed.
NCT06295835 reports 4 study locations spanning 4 distinct geographic areas - top geographies include Maryland, Pennsylvania, Washington.
Frequently Asked Questions
What is clinical trial NCT06295835 about?
NCT06295835 is a clinical study titled "Method Comparison Study for Measuring Potassium (K) and Ionized Calcium (iCa) in Blood". Method comparison study for Potassium (K) and ionized calcium (iCa).
What is the current status of trial NCT06295835?
This trial is currently completed. It is a NA study. The enrollment target is 232 participants. The study started on 2024-05-31. Estimated completion is 2025-01-29.
What conditions does trial NCT06295835 study?
This clinical trial studies the following conditions: Potassium (K) & Ionized Calcium (iCa) in Capillary Whole Blood.
What interventions are being tested in trial NCT06295835?
The interventions under investigation include: Fingerstick blood draw (DIAGNOSTIC_TEST).
Who is sponsoring clinical trial NCT06295835?
This trial is sponsored by Abbott Point of Care, which has 8 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06295835 being conducted?
This trial has 4 study locations across Maryland, Pennsylvania, Washington, Ontario. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.